Clinical Trial Update: Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating cetuximab, leucovorin, oxaliplatin, and fluorouracil with or without bevacizumab in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Avastin (bevacizumab)
• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: UNKNOWN